Literature DB >> 14674708

Curcumin inhibits ultraviolet light induced human immunodeficiency virus gene expression.

Mohiuddin M Taher1, Guido Lammering, Chad Hershey, Kristoffer Valerie.   

Abstract

Recently, we reported that the herbal drug St. John's Wort is a potent inhibitor of UV-induced HIV-LTR activation in stably transfected HIVcat/HeLa cells. Our previous studies have demonstrated that the activation of p38 MAP kinase (stress-activated protein kinase-2) and NF-kappaB are both required for a full UV-induced HIV gene expression response. In this study we have investigated the mechanism by which curcumin inhibits UV-activated HIV-LTR gene expression. We found that treatment of HIVcat/HeLa cells with micromolar concentrations of curcumin completely abolished UV activation of HIV gene expression. Curcumin treatment at similar doses as those used to inhibit HIV gene expression also effectively blocked UV activation of NF-kappaB, as demonstrated by electrophoretic mobility shift assay. In contrast, curcumin did not inhibit UV-induced phosphorylation of p38 MAP kinase. This observation was also supported by findings that curcumin did not inhibit UV-induced phosphorylation of CREB/ATF-1 and ATF-2. Although curcumin was ineffective in preventing UV-induced p44/42 MAP kinase phosphorylation, the JNK (1 and 2) and AP-1 activation were efficiently blocked by curcumin in HeLa cells. We conclude that the mechanism by which curcumin modulates UV activation of HIV-LTR gene expression mainly involves the inhibition of NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14674708     DOI: 10.1023/a:1027393719610

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  53 in total

1.  Myb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR-mediated transcription.

Authors:  P Dasgupta; P Saikumar; C D Reddy; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 2.  Protein kinase cascades activated by stress and inflammatory cytokines.

Authors:  J M Kyriakis; J Avruch
Journal:  Bioessays       Date:  1996-07       Impact factor: 4.345

Review 3.  Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development.

Authors:  Y T Ip; R J Davis
Journal:  Curr Opin Cell Biol       Date:  1998-04       Impact factor: 8.382

4.  Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus.

Authors:  B Klaver; B Berkhout
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

Review 5.  Transcriptional regulation by extracellular signals: mechanisms and specificity.

Authors:  C S Hill; R Treisman
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

6.  ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB.

Authors:  X Yang; Y Chen; D Gabuzda
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

7.  Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells.

Authors:  A Khar; A M Ali; B V Pardhasaradhi; Z Begum; R Anjum
Journal:  FEBS Lett       Date:  1999-02-19       Impact factor: 4.124

Review 8.  Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities.

Authors:  S T Butera
Journal:  Antiviral Res       Date:  2000-12       Impact factor: 5.970

9.  Activation of human immunodeficiency virus type 1 by DNA damage in human cells.

Authors:  K Valerie; A Delers; C Bruck; C Thiriart; H Rosenberg; C Debouck; M Rosenberg
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

10.  Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.

Authors:  C J Li; L J Zhang; B J Dezube; C S Crumpacker; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 12.779

View more
  7 in total

1.  Epigenetic changes induced by curcumin and other natural compounds.

Authors:  Simone Reuter; Subash C Gupta; Byoungduck Park; Ajay Goel; Bharat B Aggarwal
Journal:  Genes Nutr       Date:  2011-04-24       Impact factor: 5.523

2.  Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents.

Authors:  G Kaur; N Tirkey; S Bharrhan; V Chanana; P Rishi; K Chopra
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Adaptogenic potential of curcumin in experimental chronic stress and chronic unpredictable stress-induced memory deficits and alterations in functional homeostasis.

Authors:  Nitish Bhatia; Amteshwar Singh Jaggi; Nirmal Singh; Preet Anand; Ravi Dhawan
Journal:  J Nat Med       Date:  2011-04-11       Impact factor: 2.343

Review 4.  Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals.

Authors:  Xionghao Lin; Tatyana Ammosova; Namita Kumari; Sergei Nekhai
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

5.  Curcumin-loaded apotransferrin nanoparticles provide efficient cellular uptake and effectively inhibit HIV-1 replication in vitro.

Authors:  Upendhar Gandapu; R K Chaitanya; Golla Kishore; Raju C Reddy; Anand K Kondapi
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

6.  Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys.

Authors:  Naveen Tirkey; Gaganjit Kaur; Garima Vij; Kanwaljit Chopra
Journal:  BMC Pharmacol       Date:  2005-10-15

Review 7.  A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin.

Authors:  Shivkanya Fuloria; Jyoti Mehta; Aditi Chandel; Mahendran Sekar; Nur Najihah Izzati Mat Rani; M Yasmin Begum; Vetriselvan Subramaniyan; Kumarappan Chidambaram; Lakshmi Thangavelu; Rusli Nordin; Yuan Seng Wu; Kathiresan V Sathasivam; Pei Teng Lum; Dhanalekshmi Unnikrishnan Meenakshi; Vinoth Kumarasamy; Abul Kalam Azad; Neeraj Kumar Fuloria
Journal:  Front Pharmacol       Date:  2022-03-25       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.